Alison Tree1
1Royal Marsden NHS Foundation Trust, Urology, Sutton, Surrey, United Kingdom
We will present the wealth of data suggesting better outcomes after SBRT in the treatment of metastatic disease, including biological, observational and randomised data. We will explain why it is good for the radiotherapy community to embrace change and be ready to move the field forward.